CIK 0001851484 · <br>Emerging growth company
CITIUS ONCOLOGY, INC.
Sign in to watch- Ticker
- CTOR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 994362660
- Phone
- (908) 967-6677
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- TenX Keane Acquisition
- NT 10-Q Other NT 10-Q
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Other events
- SC 13G Stake Amended Statement of Ownership
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 12 of 14 · 268 filings